The Proton Therapy Market attained a value of USD 1.31 billion in 2024 . The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 12.40%, to reach USD 4.23 billion by 2034 .
The proton therapy market value is also anticipated to grow with increasing encouragement by regulatory authorities like American Society for Radiation Oncology (ASTRO) to apply the therapy on patients. Consequently, new age pharmaceutical companies are now dedicated to use the therapy. In September 2023, Shuttle Pharmaceuticals Holdings, Inc. conveyed their commitment to employ the treatment on patients at the Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair.
The market is anticipated to grow with the rising set up proton system into the existing infrastructure. In October 2023, Hitachi launched Southeast Asia's first proton therapy system in National Cancer Centre Singapore (NCCS). This system is equipped with four rotating gantries and a Real-time image Gating system for Proton Therapy (RGPT) to treat tumours in motion due to respiration. It is also enabled with advanced spot scanning technology to precisely irradiate tumors with compound shapes.
Having several academic and healthcare institutions at home, Europe holds a massive market share as well. With the help of numerous awareness and educational campaigns, there is emphasis on educating the healthcare staff with the technical knowledge of using all the latest technologies.
The Asia Pacific region, on the other hand, is projected to encounter an upswing in the proton therapy market growth in the foreseeable future. With high national and foreign investments, emerging markets like India are continuously improving their research and healthcare infrastructure. Major healthcare companies are also investing in the Asian markets to leverage the easy availability of resources present in the region.
This product will be delivered within 3-5 business days.
Proton Therapy: Introduction
Proton therapy is a type of radiation therapy that treats cancer with the help of positively charged ions (protons). It may also be used in the treatment of some noncancerous tumours or in conjunction with treatments like chemotherapy or surgery. Proton therapy has garnered high popularity owing to its minimal side effects when compared to conventional methods as doctors have better hold at controlling the site of energy accumulation.Global Proton Therapy Market Analysis
The rising prevalence of cancer is a major factor leading to proton therapy market demand. While radiation has been a common part of cancer treatment, proton therapy is now gaining popularity owing to its minimal side effects when compared to traditional radiotherapy. It also facilitates the patients to continue with day-to-day lives owing to its painless nature.The proton therapy market value is also anticipated to grow with increasing encouragement by regulatory authorities like American Society for Radiation Oncology (ASTRO) to apply the therapy on patients. Consequently, new age pharmaceutical companies are now dedicated to use the therapy. In September 2023, Shuttle Pharmaceuticals Holdings, Inc. conveyed their commitment to employ the treatment on patients at the Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair.
The market is anticipated to grow with the rising set up proton system into the existing infrastructure. In October 2023, Hitachi launched Southeast Asia's first proton therapy system in National Cancer Centre Singapore (NCCS). This system is equipped with four rotating gantries and a Real-time image Gating system for Proton Therapy (RGPT) to treat tumours in motion due to respiration. It is also enabled with advanced spot scanning technology to precisely irradiate tumors with compound shapes.
Global Proton Therapy Market Segmentation
Global Proton Therapy Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:Market Breakup by Product Type
- Systems
- Accelerators Cyclotrons Synchrotrons
- Beam Delivery Pencil Beam Scanning Passive Scattering Uniform Scanning
- Modulators
- Others
- Software
- Services
Market Breakup by Components
- Proton Accelerator
- Cyclotrons
- Synchrotrons
- Synchrocyclotrons
- Linacs
- H-Minus Synchrotrons
- Separated Sector Cyclotrons
- Super-Conducting Cyclotrons
- Fast Cycling Synchrotron
- Beam Delivery System
- The Passive Scattering Technique
- Beam Scanning
- Nozzle
- Pencil Scanning Nozzle
- Single Scattering
- Double Scattering
- Uniform Scanning Nozzle
- Image Viewers
- Beam Transport System
- Patient Positioning System (PPS)
Market Breakup by Type
- Rotating Proton Therapy Systems
- Non-Rotating Proton Therapy Systems
Market Breakup by Set-Up Systems
- Multi-Room Systems
- Single-Room Systems
Market Breakup by Applications
- Treatment Applications
- Ediatric Cancer
- Tumours in the Base of the Skull
- Prostate Cancer
- Head and Neck Cancer
- Breast Cancer
- Lung Cancer
- Tumours Affecting Spine
- Eye Melanoma
- Lymphoma
- Pituitary Gland Tumours
- Others
- Research Applications
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centres
- Cancer Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Proton Therapy Market Overview
The United States alone is expected to record around 1,958,310 new cancer cases in 2023, hence, it is anticipated to hold a major part of the global proton therapy market share in upcoming years. Having a well-structured infrastructure that can easily adopt newer technologies is another essential component of the large market size. The region is experiencing validation from numerous upcoming companies which are willingly adapting to the latest techniques and devising better means of application.Having several academic and healthcare institutions at home, Europe holds a massive market share as well. With the help of numerous awareness and educational campaigns, there is emphasis on educating the healthcare staff with the technical knowledge of using all the latest technologies.
The Asia Pacific region, on the other hand, is projected to encounter an upswing in the proton therapy market growth in the foreseeable future. With high national and foreign investments, emerging markets like India are continuously improving their research and healthcare infrastructure. Major healthcare companies are also investing in the Asian markets to leverage the easy availability of resources present in the region.
Global Proton Therapy Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Varian Medical Systems, Inc.
- IBA Group
- Hitachi, Ltd.
- Mevion Medical Systems, Inc.
- Sumitomo Heavy Industries, Ltd.
- Optivus Proton Therapy, Inc.
- ProTom International, Inc.
- Advanced Oncotherapy Plc.
- ProNova Solutions, LLC
- Mitsubishi Electric Corporation
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Global Proton Therapy Market Overview
4 Global Proton Therapy Market Landscape
5 Global Proton Therapy Market Dynamics
6 Global Proton Therapy Market Segmentation
7 North America Proton Therapy Market
8 Europe Proton Therapy Market
9 Asia Pacific Proton Therapy Market
10 Latin America Proton Therapy Market
11 Middle East and Africa Proton Therapy Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Proton Therapy Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Varian Medical Systems, Inc.
- IBA Group
- Hitachi, Ltd.
- Mevion Medical Systems, Inc.
- Sumitomo Heavy Industries, Ltd.
- Optivus Proton Therapy, Inc.
- ProTom International, Inc.
- Advanced Oncotherapy Plc.
- ProNova Solutions, LLC
- Mitsubishi Electric Corporation